Amanote Research
Register
Sign In
Is Angiogenesis Essential for the Progression of Hematological Malignancies or Is It an Epiphenomenon?
Leukemia
- United Kingdom
doi 10.1038/leu.2008.381
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
March 1, 2009
Authors
D Ribatti
Publisher
Springer Science and Business Media LLC
Related search
Tissue Factor as an Effector of Angiogenesis and Tumor Progression in Hematological Malignancies
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Is It or Is It Not a Pathogenic Mutation? Is It or Is It Not the Podocyte?
Journal of Nephropathology
Nephrology
Fungus or Cancer: Is It or Is It Not?
Archives in Biomedical Engineering & Biotechnology
Is It In, or Is It Out?
Journal of Biological Rhythms
Physiology
MacCallum's Triangle - Is It Rheumatic? Is It Traumatic? Or Is It Both?
Microscopy and Microanalysis
Instrumentation
Β1 Integrin Is Essential for Teratoma Growth and Angiogenesis
Journal of Cell Biology
Medicine
Cell Biology
Timing Is Everything—Or Is It?
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
The Rule of the Artery Is Supreme. Or, Is It?
Journal of the American Osteopathic Association, The
Medicine
Alternative Medicine
Complementary
Is Metabolic Syndrome Truly a Risk Factor for Male Lower Urinary Tract Symptoms or Just an Epiphenomenon?
Advances in Urology
Gynecology
Urology
Obstetrics